0. Advocacy Webpage Graphics-Narrow -Standardize It 

There are many misconceptions about the disease of addiction, and a culture change is needed in this country to drive patients to the treatment options that have been proven to be effective at reducing overdose deaths and supporting patients in remission and recovery.

It is critical that our treatment infrastructure reflect this by facilitating the use of evidence-based, research-validated guidelines and standards for the treatment of addiction and employing competency-based addiction education for all healthcare providers.





The ASAM Criteria®, the most widely used and comprehensive set of guidelines for placement, continued stay and transfer/discharge of patients with addiction and co-occurring conditions, is a fundamental tool for the standardization of addiction medicine.



 
ASAM Level of Care Cert final
 




Featured Public Policy Statements

0. doctor patient

Regulation of Office-Based Opioid Treatment

OBOT promotes the treatment of addiction in the primary care setting, but ASAM understands that the use of controlled substances to treat addiction introduces the possibility of misuse and diversion of the very medications used for treatment.
2. medical-recordscrop

Prescription Drug Monitoring Programs (PDMPs)

Find out more about PDMPs and ASAM's recommendations on how they should be regulated.

Worldgen

Joint Public Correctional Policy Statement on the Treatment of Opioid Use Disorders for Justice Involved Individuals

Learn more about how ASAM and the American Correctional Association (ACA) are supporting the use of evidence-based practices for the treatment of opioid use disorders in correctional settings.





"By implementing a quality-driven national addiction treatment infrastructure, we can empower patients and their families with information on how to identify and access high-quality treatment."

-Kelly Clark, MD, MBA, DFASAM
Immediate-Past President of ASAM




Resources

dtd-webpage-title-banner

Appropriate Use of Drug Testing in Clinical Addiction Medicine

Provides guidance about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction.

guideline-webpage-title-banner-1

The ASAM National Practice Guideline

The ASAM National Practice Guideline and associated resources provide information on evidence-based treatment of opioid use disorder.

confidentiality_472x176aa36159472bc604ca5b7ff000030b21a

Confidentiality (42 CFR Part 2)

Learn how ASAM continues to call for needed privacy protections as 42 CFR Part 2 regulations and the underlying statute are updated. 




Related News

newspapers-3488857_1920B

146 Members of the Coalition to Stop Opioid Overdose and Other Organizations Issue Letter of Support for the CARE Act of 2019

by | May 08, 2019

Download Letter

ASAM joined 145 members of the Coalition to Stop Opioid Overdose (CSOO) and other organizations in sending a letter voicing support for the Comprehensive Addiction Resources Emergency (CARE) Act of 2019. Modeled directly on the Ryan White Act, the CARE Act of 2019 would provide $100 billion in federal funding over the next ten years to states, local governments, and other organizations and institutions to support federal research and programs to prevent drug use while expanding access to prevention, harm reduction, addiction treatment, mental health services, and recovery support services.

The letter emphasizes how this level of authorized funding is critical in order to build comprehensive systems that are both effective and sustainable. In addition, the letter highlights how the CARE Act would incent systemic changes to facilitate adoption of evidence-based practices including the implementation of nationally recognized level of care standards for addiction treatment programs and new standards for recovery residence. The letter also highlights how the CARE Act would help grow our mental health and addiction services workforce by improving training for healthcare professionals who care for patients with mental health and substance use disorders in communities across the US.